Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:42 PM
Ignite Modification Date:
2025-12-24 @ 2:42 PM
NCT ID:
NCT05567159
Eligibility Criteria:
Inclusion Criteria:
* Participants who are overtly healthy as determined by medical evaluation
* Have a body mass index (BMI) of 19.0 and 32.0, kilograms per meter squared (kg/m²), inclusive.
* Females of childbearing potential will be excluded from the study.
Exclusion Criteria:
* Have allergies to either humanized monoclonal antibodies, diphenhydramine, epinephrine, or methylprednisolone
* Have a history within the past 5 years of a primary or recurrent malignant disease
* Have used over-the-counter or prescription medications, including herbal medication, within 7 days prior to dosing
* Are pregnant or intend to become pregnant or to breastfeed during the study
* Smoke more than 10 cigarettes per day or are unable to abide by investigative site smoking restrictions
* Have a history of intracranial hemorrhage, cerebrovascular aneurysm or arteriovenous malformation, carotid, carotid artery occlusion, stroke or epilepsy or family history of dementia or Down's syndrome
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT05567159
Study Brief:
Protocol Section:
NCT05567159